Jennifer Abrams
About Jennifer Abrams
Jennifer Abrams is a Senior Manager of Project Management at Sonoma Biotherapeutics, where she focuses on drug discovery research related to cardio-metabolic diseases. She has a diverse background in biomedical research and project management, having held various roles at notable organizations including Merck and Afferent Pharmaceuticals.
Current Role at Sonoma BioTherapeutics
Jennifer Abrams serves as Senior Manager of Project Management at Sonoma BioTherapeutics, a position she has held since 2021. In this role, she focuses on managing projects related to drug discovery and development, particularly in the area of cardio-metabolic diseases. She utilizes her expertise in cell biology, biochemistry, and genetics to investigate targets that may have disease-modulating potential.
Previous Experience at Precision For Medicine
Before joining Sonoma BioTherapeutics, Jennifer worked as Director of Business Development at Precision For Medicine from 2020 to 2021. During her tenure in the San Francisco Bay Area, she contributed to the company's strategic initiatives and business growth, leveraging her background in project management and scientific research.
Research Background and Experience
Jennifer has a robust research background, having worked as a Research Associate at Afferent Pharmaceuticals (Merck) from 2015 to 2016. She also held the position of Senior Scientist at Merck from 2017 to 2020. Her experience includes conducting drug discovery research and utilizing various biological tools to understand disease mechanisms.
Educational Qualifications
Jennifer holds a Doctor of Philosophy (PhD) in Microbiology and Molecular Genetics from The University of Texas Health Science Center at Houston, where she studied from 2007 to 2014. She also earned a Bachelor of Science in Biotechnology from the University of Houston-Downtown, studying from 2005 to 2007. Additionally, she has experience as a Student Research Assistant at Texas A&M University.
Skills and Research Focus
In her current role, Jennifer utilizes her skills in cell biology, biochemistry, and genetics to investigate disease progression mechanisms. Her research is particularly focused on drug discovery related to cardio-metabolic diseases, where she applies her knowledge to identify potential therapeutic targets.